New Flurbiprofen Derivatives: Synthesis, Membrane Affinity and Evaluation of in Vitro Effect on β-Amyloid Levels
Alzheimer’s disease (AD) is characterized by irreversible and progressive loss of memory and cognition and profound neuronal loss. Current therapeutic strategies for the treatment of AD have been directed to a variety of targets with the aim of reversing or preventing the disease but, unfortunately,...
Main Authors: | Stephanie Pacella, Lucia Grumetto, Francesco Barbato, Dario Ambrosini, Gianfabio Giorgioni, Hasan Türkez, Antonella Fontana, Ivana Cacciatore, Lisa Marinelli, Piera Sozio, Amelia Cataldi, Antonio Di Stefano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/18/9/10747 |
Similar Items
-
Modulation of γ-Secretase Activity by a Carborane-Based Flurbiprofen Analogue
by: Stefan Saretz, et al.
Published: (2021-05-01) -
The Comparison of Plasma and Cerebrospinal Fluid R(−)- and S(+)-Flurbiprofen Concentration After Intravenous Injection of Flurbiprofen Axetil in Human Subjects
by: Han Yao, et al.
Published: (2021-04-01) -
Soluble Gamma-secretase Modulators Attenuate Alzheimer's β-amyloid Pathology and Induce Conformational Changes in Presenilin 1
by: Frank Raven, et al.
Published: (2017-10-01) -
Modulation of γ-secretase by EVP-0015962 reduces amyloid deposition and behavioral deficits in Tg2576 mice
by: Rogers Kathryn, et al.
Published: (2012-12-01) -
Matriptase cleaves the amyloid-beta peptide 1–42 at Arg-5, Lys-16, and Lys-28
by: Li-Mei Chen, et al.
Published: (2019-01-01)